Insights
Publications

Patent Exhaustion Does Not Apply to the Reproduction of Patented Seeds

5/14/2013 Articles

On May 13, the United States Supreme Court issued its decision in Bowman v. Monsanto Co., 569 U.S. ___ (2013), which concerned whether and how patent exhaustion applies to self-replicating patented articles.  Monsanto patented genetically modified soybean seeds that were resistant to glyphosate herbicide.  Monsanto or its affiliates sold these seeds to farmers subject to a license under which the farmer agreed not to use the progeny of the seeds for later re-planting, nor to supply them to others to do the same.  However, farmers could sell the progeny seeds to grain elevators as a commodity without restriction on the grain elevators’ subsequent sales of the seeds.  Grain elevators typically buy grain from farmers and sell it for consumption, not for use as agricultural seed.  Commodity seeds are a mixture of seeds harvested from various sources, and thus may include progeny of Monsanto’s patented seeds.

 

An Indiana farmer, Vernon Hugh Bowman, bought some of the patented soybean seeds from one of Monsanto’s licensed seed producers.  He planted these seeds and harvested the plants, but, as required by the license, did not save seeds from this harvest for later replanting.  However, he also bought commodity seeds from a grain elevator, planted them, grew them, applied glyphosate herbicide to them, harvested the plants that survived, saved those plants’ seeds, and then used those seeds for subsequent re-plantings.  Bowman harvested eight crops this way.  Monsanto sued Bowman for patent infringement, and, sure enough, it turned out that the progeny of the commodity seeds Bowman had planted contained Monsanto’s patented genetic modification.  The District Court granted summary judgment of infringement in Monsanto’s favor, and the United States Court of Appeals for the Federal Circuit affirmed.   The Supreme Court granted Bowman’s petition for a writ of certiorari.

 

Relying on the Court’s earlier decision in Quanta Computer, Inc. v. LG Elecs., Inc., 553 U.S. 617 (2008), Bowman argued that the doctrine of patent exhaustion – also referred to as the first sale doctrine – applied to the commodity seeds that he had purchased from the grain elevator.  According to Bowman, those seeds had been the subject of at least three prior authorized sales:  the first generation seed from Monsanto to farmers, then the second generation seed from farmers to grain elevators, and finally the second generation seed from grain elevators to Bowman.  Bowman argued that what he was doing with the commodity seeds was merely “using” them for planting.  Bowman did concede, however, that patent exhaustion did not extend to the “making” of a new patented article. 

 

Monsanto countered that seeds growing from the replanting of the commodity seeds was in fact a “making” of new patented articles, and that because these new articles were never subject to any sale, the seeds resulting from the planting of the progeny could not have been subject to patent exhaustion.  Monsanto also argued that if the Court agreed that the first sale of a living organism containing a biological invention exhausted all rights in its progeny, innovation in biotechnology would be devastated.  Furthermore, according to Monsanto, contract law could not substitute for patent protection, as Monsanto could not enter into a contract with every entity who might appropriate its technology, nor could a contracting party compensate Monsanto for all damages caused by downstream growers who misappropriate the technology.

 

A unanimous Court sided with Monsanto, holding that “the exhaustion doctrine does not enable Bowman to make additional patented soybeans without Monsanto’s permission (either express or implied).  And that is precisely what Bowman did.”  (emphasis in original).  Policy was not on Bowman’s side, for “[w]ere the matter otherwise, Monsanto’s patent would provide scant benefit.”  In the final paragraph of the decision, however, the Court did limit its holding, stating that it did not necessarily apply to every invention involving a self-replicating product.  In the case before the Court, Bowman seemed to know exactly what he was doing and took deliberate steps to “make” and market new infringing articles by planting and harvesting the patented seeds.  However, “[i]n another case, the article’s self-replication might occur outside the purchaser’s control.  Or it might be a necessary but incidental step in using the item for another purpose.”  The Court did not provide examples of where these circumstances might be present, or whether such circumstances would excuse the accused infringer of liability if they were.  Nonetheless, the Court’s cautious words may suggest that the Court would be uneasy holding an accused infringer strictly liable for patent infringement when he has been “contaminated” with a self-replicating patented article, such as patented seeds that have been blown into his fields, or where the patented article must be reproduced in order to be useful, such as patented cells that must be “grown up” in order to produce sufficient amounts of a protein to be studied or sold.  These open issues, which could have a significant impact on biotechnology companies, must wait to be resolved until another day.

Firm Highlights

News

Farella Attorneys Named to 2022 Northern California Super Lawyers and Rising Stars

Thirty-four Farella Braun + Martel lawyers were named to the Super Lawyers and Rising Stars lists of top attorneys in Northern California for 2022. Super Lawyers: Carly Alameda – Business Litigation George Argyris &ndash...

Read More
Event

How hiQ Labs v. LinkedIn and Cases Following It Have Changed U.S. Law on Scraping

Alex Reese is a speaker at OxyCon's 2022 web scraping conference for the session "How hiQ Labs v. LinkedIn and Cases Following It Have Changed U.S. Law on Scraping." To register for the conference, please click...

Read More
Publication

Importance of Monetizing Intellectual Property Assets of a Portfolio Company

In this Upside episode, we explore developing and monetizing intellectual property assets of a portfolio company. How does a new company go about developing a patent portfolio? And why spend the time and effort...

Read More
News

50 Farella Lawyers in 2023 The Best Lawyers in America® and the Best Lawyers: Ones to Watch in America™; 4 Lawyer of the Year Awards

Read More
Publication

PTO Director’s Fintiv Guidance Gives Petitioners New Tools to Avoid Discretionary Denial

The PTAB’s 2020 Fintiv decision established six factors that guide its discretionary denial of an IPR or PGR petition in view of a parallel court case.  The Fintiv factors give significant weight to scheduling...

Read More
Publication

Platform Ecosystems: Computer Fraud and Abuse Act and Other Scraping Law Developments (Webinar)

Stephanie Skaff and Erik Olson discuss "Platform Ecosystems: Computer Fraud and Abuse Act and Other Scraping Law Developments." Web scraping has existed as long as the World Wide Web has, and as data has...

Read More
Publication

Platform Ecosystems – The Landscape of US and EU Legislation (Webinar)

Stephanie Skaff and Nate Garhart discuss "Platform Ecosystems – The Landscape of US and EU Legislation." Several new bills targeting online platform companies are making their way through state and federal legislative bodies in the...

Read More
News

Managing Intellectual Property's IP Stars 2022 Ranks Farella Braun + Martel Lawyers; Firm Recommended for Patent Litigation

Farella Braun + Martel’s Daniel Callaway , James L. Day , Jeffrey M. Fisher , Winston Liaw , Eugene Mar , and Stephanie P. Skaff were recognized by Managing Intellectual Property in the 2022...

Read More
Publication

7 Tips to Help Financial Advisor Firms Protect Their Customer Lists

Customer relationships are a key asset for companies in the financial advising and wealth management industry. In California, however, the law is making it increasingly difficult to stop departing employees from soliciting customers after...

Read More
News

Chambers USA 2022 Recognizes Farella Braun + Martel Lawyers, Practices

Farella Braun + Martel is pleased to announce that Chambers USA has recognized 14 lawyers and 6 practice areas in the legal directory’s 2022 edition. Individual California and Western U.S. Rankings: Sarah Bell &ndash...

Read More